Researchers developed a cysteine-modified hyaluronic acid (HA-Cys) bioink with potassium iodide for ultra-fine 3D bioprinting. It offers rapid gelation, antioxidant protection, and high cell viability, ideal for building in vitro disease models and regenerative structures.
